Prime Minister Narendra Modi on Tuesday reviewed the current status of India's efforts in coronavirus vaccine development, drug discovery, diagnosis and testing.
He chaired a meeting of a task force on coronavirus vaccine development.
The review by the prime minister took note of the extraordinary coming together of academia, industry and government, combined with speedy but efficient regulatory process, an official statement said.
Modi felt that such coordination and speed should be embedded into a standard operating procedure.
"He emphasised that what is possible in a crisis should be a part of our routine way of scientific functioning," the statement said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.